Description

This ELISA test measures IgG antibodies against Beta-2 Glycoprotein, which are associated with antiphospholipid syndrome, an autoimmune disorder that increases the risk of blood clots. It is a key test for diagnosing autoimmune clotting disorders and managing associated conditions.